Cargando…
Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin–EGFR crosstalk
Hereditary diffuse gastric cancer is a cancer predisposition syndrome associated with germline mutations of the E-cadherin gene (CDH1; NM_004360). Male CDH1 germline mutation carriers have by the age of 80 years an estimated 70% cumulative incidence of gastric cancer, females of 56% for gastric and...
Autores principales: | Li, Dandan, Lo, Winifred, Rudloff, Udo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821620/ https://www.ncbi.nlm.nih.gov/pubmed/29468433 http://dx.doi.org/10.1186/s40169-018-0184-7 |
Ejemplares similares
-
Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer
por: Chen, Ina, et al.
Publicado: (2017) -
The Merging of Biological and Electronic Circuits
por: Teo, Jonathan J.Y., et al.
Publicado: (2020) -
E-Cadherin Destabilization Accounts for the Pathogenicity of Missense Mutations in Hereditary Diffuse Gastric Cancer
por: Simões-Correia, Joana, et al.
Publicado: (2012) -
Ocular Surface – Merging Challenges and Opportunities
por: Araj, Houmam, et al.
Publicado: (2020) -
Merging the exposome into an integrated framework for “omics” sciences
por: Price, Elliott J., et al.
Publicado: (2022)